Evidence map›Paper›PMID 37687199›Full record

ReviewMolecules (Basel, Switzerland)2023

Herbal Medicine Nanocrystals: A Potential Novel Therapeutic Strategy.

Mengran Guo, Shugang Qin, Shiyan Wang, Min Sun, Huiling Yang, Xinchun Wang, Ping Fan, Zhaohui Jin

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
11.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. High Flavonoid Content inPharmaceutical nanotechnology · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mengran GuoDepartment of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China.ORCID 0000-0001-5976-6383
Shugang QinDepartment of Critical Care Medicine, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Shiyan WangDepartment of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China.
Min SunFirst Affiliated Hospital of the Medical College, Shihezi University, Shihezi 832008, China.
Huiling YangFirst Affiliated Hospital of the Medical College, Shihezi University, Shihezi 832008, China.
Xinchun WangFirst Affiliated Hospital of the Medical College, Shihezi University, Shihezi 832008, China.
Ping FanDepartment of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China.
Zhaohui JinDepartment of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China.
Sichuan University · CNFirst Affiliated Hospital of Shihezi University Medical College · CN

Funding

National Key Clinical Specialties Construction Program, the Youth Fund of National Natural Sci-ence Foundation of China 82104081Science and Technology Project of Xinjiang Production and Construction Corps 2022AB020Sichuan Province Science and Technology Support Program 2023NSFSC1682
6 · The paper itself

Abstract

Herbal medicines have gained recognition among physicians and patients due to their lower adverse effects compared to modern medicines. They are extensively used to treat various diseases, including cancer, cardiovascular issues, chronic inflammation, microbial contamination, diabetes, obesity, and hepatic disorders, among others. Unfortunately, the clinical application of herbal medicines is limited by their low solubility and inadequate bioavailability. Utilizing herbal medicines in the form of nanocrystals (herbal medicine nanocrystals) has shown potential in enhancing solubility and bioavailability by reducing the particle size, increasing the specific surface area, and modifying the absorption mechanisms. Multiple studies have demonstrated that these nanocrystals significantly improve drug efficacy by reducing toxicity and increasing bioavailability. This review comprehensively examines therapeutic approaches based on herbal medicine nanocrystals. It covers the preparation principles, key factors influencing nucleation and polymorphism control, applications, and limitations. The review underscores the importance of optimizing delivery systems for successful herbal medicine nanocrystal therapeutics. Furthermore, it discusses the main challenges and opportunities in developing herbal medicine nanocrystals for the purpose of treating conditions such as cancer, inflammatory diseases, cardiovascular disorders, mental and nervous diseases, and antimicrobial infections. In conclusion, we have deliberated regarding the hurdles and forthcoming outlook in the realm of nanotoxicity, in vivo kinetics, herbal ingredients as stabilizers of nanocrystals, and the potential for surmounting drug resistance through the utilization of nanocrystalline formulations in herbal medicine. We anticipate that this review will offer innovative insights into the development of herbal medicine nanocrystals as a promising and novel therapeutic strategy.

Indexed as

NanoparticlesPlants, MedicinalBiological AvailabilityHerbal MedicineHumansPlant ExtractsPlant Extractsapplicationsdrug deliveryherbal medicinenanocrystalsnucleation and polymorphismpreparation

Identifiers

PMID37687199
PMCPMC10489021
OpenAlexW4386332316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.